The O-glycan array can be used as a research tool to determine the immunodominant epitopes of O-glycans in cancer, or to sensitively detect the glycan binding epitopes of autoantibodies that target unique O-glycan antigens.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
